Weiping Wang
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Pharmaceutical Science top 1%
Papers in
-
- Advanced biosensing and bioanalysis techniques 11
- RNA Interference and Gene Delivery 9
-
- Nanoplatforms for cancer theranostics 41
- Co-authors
- Daniel S. Kohane (19 shared papers)Alina Y. Rwei (5 shared papers)Marc W. Kirschner (5 shared papers)Changyou Zhan (16 shared papers)Yafei Li (10 shared papers)Ying Chau (5 shared papers)Chunyan Zhou (12 shared papers)Kaiqi Long (22 shared papers)
- Journals
- Advanced Science (9 papers)Nano Letters (7 papers)Advanced Healthcare Materials (5 papers)PLoS ONE (4 papers)ACS Nano (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Weiping Wang
238 papers receiving 6.4k citations
Peers
Comparison fields: 5 of 177
- Biomaterials 1.1k
- Pharmaceutical Science 291
- Biological Psychiatry 101
- Biomedical Engineering 1.9k
- Molecular Biology 2.2k
Countries citing papers authored by Weiping Wang
This map shows the geographic impact of Weiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Wang more than expected).
Fields of papers citing papers by Weiping Wang
This network shows the impact of papers produced by Weiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Wang. The network helps show where Weiping Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 280 | |
| 2 | 2017 | 248 | |
| 3 | 2017 | 197 | |
| 4 | 2006 | 138 | |
| 5 | 2018 | 132 | |
| 6 | 2017 | 119 | |
| 7 | 2010 | 115 | |
| 8 | 2015 | 113 | |
| 9 | 2014 | 105 | |
| 10 | 2006 | 99 | |
| 11 | 1994 | 99 | |
| 12 | 2009 | 99 | |
| 13 | 2019 | 96 | |
| 14 | 2013 | 92 | |
| 15 | 2012 | 90 | |
| 16 | 2020 | 88 | |
| 17 | 2011 | 82 | |
| 18 | 2015 | 82 | |
| 19 | 2014 | 81 | |
| 20 | 2019 | 78 |
About Weiping Wang
Weiping Wang is a scholar working on Molecular Biology, Biomedical Engineering, Materials Chemistry, Surgery and Biomaterials, having authored 250 papers that have together received 6.4k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (41 papers), Photochromic and Fluorescence Chemistry (15 papers), Luminescence and Fluorescent Materials (14 papers), Advanced biosensing and bioanalysis techniques (11 papers), Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (9 papers), Pancreatic function and diabetes (8 papers) and Microtubule and mitosis dynamics (8 papers). The work is most often cited by research in Biomaterials (1.1k citations), Pharmaceutical Science (291 citations), Biological Psychiatry (101 citations), Biomedical Engineering (1.9k citations) and Molecular Biology (2.2k citations). Weiping Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Daniel S. Kohane, Alina Y. Rwei, Marc W. Kirschner, Changyou Zhan, Yafei Li, Ying Chau, Chunyan Zhou, Kaiqi Long, S.R. Eisenberg and Weirong Kang. Their work appears in journals such as Advanced Science, Nano Letters, Advanced Healthcare Materials, PLoS ONE and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.